Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
NRX 194204
DRUG
2 trials
Sponsors
University of Southern California
, Io Therapeutics
Conditions
Castration Resistant Prostate Cancer
Refractory Malignancies
Phase 1
Oral NRX 194204 in Patients With Refractory Malignancies
Terminated
NCT00630760
University of Southern California
Refractory Malignancies
Start: 2008-02-29
End: 2010-06-30
Updated: 2014-05-21
Phase 2
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Completed
NCT01540071
Io Therapeutics
Castration Resistant Prostate Cancer
Start: 2011-08-31
End: 2015-12-31
Updated: 2021-05-14
Related Papers
An open-label phase II clinical trial of the RXR agonist IRX4204 in taxane-resistant, castration-resistant metastatic prostate cancer (CRPC).
Journal of Clinical Oncology
2014-05-20
6 citations
An open-label phase II clinical trial of the RXR agonist IRX4204 in taxane-resistant, castration-resistant metastatic prostate cancer (CRPC).
Journal of Clinical Oncology
2014-02-01
6 citations